Autism Spectrum Disorder Trial, Recruiting NCT06497920 Sponsor: Centre for Addiction and Mental Health Condition: Autism Spectrum Disorder
Back to Autism Spectrum Disorder

Autism Spectrum Disorder Trial, Recruiting

NCT06497920
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 40 years old
  • People with an IQ above 70
  • People who can read, write, and communicate effectively in English
  • People who are able to give informed consent, as assessed by a clinician
  • People with no history of seizures
  • People who are willing to follow all study procedures and sign a consent form
  • People who agree to avoid alcohol, tobacco, marijuana, and caffeine on the days of study visits

For people with Autism Spectrum Disorder (ASD), additional criteria apply:

  • A formal ASD diagnosis under DSM-5 (a standard diagnostic system), without intellectual disability, confirmed through clinical assessment and a specific autism assessment tool called the ADOS-2
  • Significant difficulties with movement or motor skills, as measured by a standardised motor skills test called the BOT-2
  • Being medically stable with no changes to medication in the past four weeks

Who may not be able to join:

  • People who are currently pregnant
  • People with a current or past serious medical condition that may need urgent medical treatment
  • People with a substance use disorder (other than tobacco) in the past six months
  • People with significant hearing or vision problems that would make it difficult to follow instructions
  • People with a serious neurological or medical illness, such as brain infections, brain tumours, aneurysms, or uncontrolled diabetes
  • People with metal implants or a pacemaker
  • People who have previously received a type of brain stimulation treatment called rTMS
  • People with ASD who are currently taking benzodiazepines or anticonvulsant medications

For neurotypical (non-autistic) participants, additional exclusions apply:

  • People who have a mental health condition other than a specific phobia, as identified through a screening assessment
  • People who have a biological family member diagnosed with Pervasive Developmental Disorder or ASD

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 4165358501

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Centre for Addiction and Mental Health
Registry
ClinicalTrials.gov
Start date
24 April 2024
Est. completion
30 April 2029

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Changes in motor cortical plasticity using motor evoked potentials (MEPs) in autistic adults following rTMS.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov